Organic Process Research & Development 2007, 11, 693−698
Process Development for ABT-472, a Benzimidazole PARP Inhibitor
Jufang H. Barkalow, Jeffrey Breting, Bruce J. Gaede,* Anthony R. Haight, Rodger Henry, Brian Kotecki, Jianzhang Mei,
Kurt B. Pearl, Jason S. Tedrow,† and Shekhar K. Viswanath
Process Chemistry and Engineering, Dept. R450, Bldg. R-8, Abbott Laboratories, 1401 Sheridan Road,
North Chicago, Illinois 60064, U.S.A.
Abstract:
°C, well above the boiling point of isopropyl acetate (85-
91 °C). The maximum rate of heat evolution ((dT/dt)max) was
reduced from 74 °C/min prior to dilution with isopropyl
acetate to less than 1 °C/min after dilution. The latter
experiment was run in the presence of stainless steel.
Slow addition of the anhydride 2 to an excess of
ammonium hydroxide yielded a 90:8:2 mixture of am-
monium salts of carboxamide 12,6 regioisomer 13,7,8 and
phthalic acid 1 (Scheme 2).9,10 Adjusting the pH of the
reaction mixture to not more than 2 with aqueous hydro-
chloric acid caused free acid 14 to precipitate in 80% yield
along with approximately 4% of the phthalic acid 1.
However, acid 14 was found to rapidly undergo isomerization
and hydrolysis to diacid 1 upon standing in acidic media
even at 0 °C.
A nine-step convergent process was developed for the synthesis
of ABT-472, a benzimidazole PARP inhibitor. The identity and
origin of several impurities were determined, and the process
was modified to reduce or eliminate these impurities. A number
of safety and control issues were investigated. The original
synthesis was shortened to 9 steps and streamlined while
maintaining a convergent strategy. A stable salt was selected,
and control of the API solid form was established. The process
was successfully scaled up to provide 8.5 kg of final product of
>99% purity in 33% yield over 9 steps.
Introduction
Poly((ADP)-ribose) polymerases (PARPs) have been
recognized as cellular signaling enzymes capable of cata-
lyzing the transfer of ADP-ribose units from NAD+ to a
number of acceptor proteins. PARP-1, the most characterized
of these polymerases, is critical to the cellular response to
DNA injury.1 Selective binding of PARP-1 to sites of both
single and double strand DNA damage ultimately results in
the repair of the break. ABT-472 (11), an inhibitor of PARP-
1, has been advanced for clinical evaluation as a potentiator
of DNA damaging radio- and chemotherapy agents.2 In order
to obtain in ViVo efficacy of ABT-472, an efficient, scalable
synthetic route is needed. In this paper we report on the
development of a route to ABT-472.
To circumvent the instability of 14 in the presence of acid,
we focused on isolation of the potassium salt 3 (Scheme 2).
The potassium salt had the favorable properties of being a
crystalline, nonhygroscopic solid that could be used directly
in the subsequent Hofmann rearrangement, and 3 could be
easily recovered by crystallization from isopropanol.11 Ad-
dition of KOH to the crude reaction mixture followed by
solvent exchange into isopropanol gave an 86% isolated yield
of 3 with 99.8% purity.
The Hofmann rearrangement (Scheme 3) has usually been
accomplished by addition of an amide to a solution of freshly
prepared potassium hypobromite followed by heating,12
although direct addition of bromine to an aqueous KOH
solution of the amide has been preferred to avoid concerns
regarding stability of the hypobromite.13 Calorimetry during
the direct addition procedure showed an exotherm of -140
Results and Discussion
Our synthesis (Scheme 1) of ABT-472 commenced with
the preparation of anhydride 2 from commercially available
3-nitrophthalic acid (1). As reported,3 dehydration with neat
acetic anhydride at 100-120 °C cleanly yielded the desired
anhydride. Reaction calorimetry showed the dehydration to
be mildly exothermic (-4.1 kcal/mol), however accelerating
rate calorimetry (ARC)4 indicated the potential for an
extremely exothermic decomposition when the mixture was
heated to greater than 100 °C in the presence of metals.5 To
safely control the reaction, the reaction mixture was diluted
with isopropyl acetate, raising the initiation point to >140
(5) (a) Tests were carried out in the presence of 316 stainless steel and titanium.
(b) Explosions with nitric acid/acetic anhydride mixtures have been reported
(Eaborn, C. J. Organomet. Chem. 1978, 144, 271. Andreozzi, R.; Marotta,
R.; Sanchirico, R. J. Haz. Matls. 2002, 90, 111. Chervin, S.; Bodman, G.
T.; Barnhart, R. W. J. Haz. Matls. 2006, 130, 48); however we are unaware
of any examples of hazardous decompositions of aromatic nitro compounds
in the presence of acetic anhydride. The mechanism of destabilization by
metals is not known.
(6) Ritzeler, O.; Stilz, H. U.; Neises, B.; Bock, W. J., Jr.; Walser, A.; Flynn,
G. A. Preparation of benzimidazolecarboxylic acid amino acid amides as
IκB kinase inhibitors. PCT Int. Appl. (2001), WO 2001000610 A1
20010104.
(7) Oku, A.; Matsui, A. Bull. Chem. Soc. Jpn. 1977, 50, 3338.
(8) The regioisomer 13 was identified by 13C NMR analysis and LC/MS.
(9) Ratio is area % based on HPLC. Variances in ratio due to sampling errors
of the heterogeneous mixture were often observed.
(10) Ammonia in THF, DME, MeOH, and IPA gave ratios of 12:13 ranging
from 32:1 to 14:1.
* To whom correspondence should be addressed. E-mail: bruce.gaede@
abbott.com.Telephone: 847-938-0730. Fax: 847-938-2258.
† Current address: Amgen, Inc., Thousand Oaks, CA 91320.
(1) Curr. Med. Chem. 2003, 10, 321.
(2) Lubisch, W.; Kock, M.; Hoger, T.; Schult, S.; Grandel, R.; Muller, R.
Preparation of benzimidazolecarboxamides as poly(ADP-ribose)polymerase
inhibitors. PCT Int. Appl. (2000), WO 2000032579 A1 20000608.
(3) Organic Synthesis, CollectiVe Volume 1; Wiley: New York, 1932; p 402.
(4) Hoppe, T. Chem. Eng. Prog. 1992, 88, 70.
(11) Potassium salt 3 had a solubility of 15 mg/mL (reported as the free acid) in
22% water/IPA at 0 to 5 °C, while the potassium salt of the regioisomer 13
had a solubility of >20 mg/mL under the same conditions.
(12) Wallis, E. S.; Lane, J. F. Organic Reactions, Vol. 3; p 267.
(13) Beckwith, R. C.; Margerum, D. W. Inorg. Chem. 1997, 36 (17), 3754.
10.1021/op7000194 CCC: $37.00 © 2007 American Chemical Society
Published on Web 05/15/2007
Vol. 11, No. 4, 2007 / Organic Process Research & Development
•
693